Gender differences in adverse drug reactions: Analysis of spontaneous reports to a Regional Pharmacovigilance Centre in France

Fundamental and Clinical Pharmacology

Volumn 16, Issue 5, 2002, Pages 343-346

  Montastruc, Jean Louis ^a   Lapeyre Mestre, Maryse ^a   Bagheri, Haleh ^a   Fooladi, Atoussa ^a  

^a TOULOUSE UNIVERSITY HOSPITAL   (France)

Author keywords

Adverse drug reactions; Drugs; Gender; Pharmacovigilance; Spontaneous reports

Indexed keywords

ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; ANTIPARASITIC AGENT; CARDIOVASCULAR AGENT; CENTRAL NERVOUS SYSTEM AGENTS; DERMATOLOGICAL AGENT; HEMATOLOGIC AGENT; HORMONE; SEX HORMONE; DRUG;

ALLERGIC REACTION; ARTICLE; BLOOD DYSCRASIA; CARDIOVASCULAR DISEASE; DRUG SURVEILLANCE PROGRAM; ELECTROLYTE DISTURBANCE; EXTRAPYRAMIDAL SYMPTOM; FRANCE; GASTROINTESTINAL DISEASE; GENDER; GROUPS BY AGE; HUMAN; NEUROPSYCHIATRY; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; ADOLESCENT; ADULT; AGED; CHILD; CLASSIFICATION; COMPARATIVE STUDY; FACTUAL DATABASE; FEMALE; INCIDENCE; INFANT; MALE; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; FEMALE; FRANCE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PHARMACEUTICAL PREPARATIONS; RISK FACTORS; SEX FACTORS;

EID: 0036433092     PISSN: 07673981     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1472-8206.2002.00100.x     Document Type: Article

References (20)

1. Jick H., Adverse Drug Reactions, in: Maonde R.F. (Ed.), Topics in Clinical Pharmacology and Therapeutics, Springer Verlag, New York, USA. 1986, pp 397-404.
2. Pouyanne P., Haramburu F., Imbs J.L., Begaud B., for the French Pharmacovigilances Centres. Admission to hospital caused by adverse drug reactions: Cross sectional incidence study. BMJ (2000) 320 1036.
3. Moore N., Biour M., Paux G. et al. Adverse drug reaction monitoring: doing it the French way. Lancet (1985) ii 1056-1058.
4. Rawlins M.D. Spontaneous reporting of adverse drug reactions. I. The data. Br. J. Clin. Pharmacol. (1988) 26 1-5.
5. Rawlins M.D. Spontaneous reporting of adverse drug reactions. II. Uses. Br. J. Clin. Pharmacol. (1988) 26 7-11.
6. Kando J.C., Yonkers K.A., Cole J.O. Gender as a risk factor for adverse events to medications. Drugs (1995) 50 1-6.
7. Begaud B., Evreux J.C., Jouglard J., Lagier G. Unexpected or toxic drug reaction assessment (imputation). Actualisation of the method used in France. Thérapie (1985) 40 111-118.
8. World Health Organization Collaborating Centre for International Drug Monitoring. Definitions - Serious, severe reactions [Letter], (1993), 2-3, 18-93.
9. Hurwitz N. Prediposing factors in adverse reactions to drugs. BMJ (1969) 1 536-539.
10. Botiger L.E. Adverse drug reactions. an analysis of 310 consecutive reports to the Swedish drug reaction committee. J. Clin. Pharmacol. (1973) 13 373-382.
11. Domecq C., Noranjo C.A., Ruiz I., Busto U. Sex-related variations in the frequency and characteristics of adverse drug reactions. Int. J. Clin. Pharmacol. Ther. Toxicol. (1980) 18 362-366.
12. Vakil B.J., Kuklarni R.D., Chafbria N.L. Intensive surveillance of adverse drug reactions. J. Clin. Pharmacol. (1987) 15 435-441.
13. Simpson J.M., Bateman D.N., Rawlins M.D. Using the Adverse Reactions Register to study the effects of age and sex on adverse drug reactions. Stat. Med. (1987) 6 863-867.
14. Martin R.M., Biswas P.N., Freemantle S.N., Pearce G.L., Mann R.D. Age and sex distribution of suspected adverse drug reactions to newly marketed drugs in general practice in England. Analysis of 48 cohort studies. Br. J. Clin. Pharmacol. (1998) 46 505-511.
15. Klein L., Klein M., Sturm H. et al. The frequency of adverse drug reactions as dependent upon age, sex and duration of hospitalization. Int. J. Clin. Pharmacol. (1976) 13 187-195.
16. Drici D.D., Clement N. Is gender a risk factor for adverse drug reactions? The example of drug-induced long QT syndrome. Drug Safety (2001) 24 575-585.
17. Rabkin J., Quitkin F., Harrison W., Tricamo E., McGrath P. Adverse reactions to monoamine oxidase inhibitorss: Part I. A comparative study. J. Clin. Psychopharmacol. (1984) 4 270-278.
18. Neutel C.I., Maxwell C.J., Appel W.C. Differences between males and females in risk of NSAID-related severe gastro-intestinal events. Pharmacoepidemiol. Drug Safety (1999) 8 501-507.
19. Harris R.Z., Benet L.Z., Schwartz J.B. Gender effects in pharmacokinetics and pharmacodynamics. Drug (1995) 50 222-239.
20. Lapeyre-Mestre M., Chastan E., Louis A., Montastruc J.L. Drug consumption in workers in France: A comparative study at a 10-year interval (1996 versus 1986). J. Clin. Epidemiol. (1999) 52 471-478.